[{"Bold":true,"Classes":"['MsoNormal']","Element":"<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX II<\/span><\/b><\/p>","HasBorder":false,"ID":"450bcb60-8946-4404-83fd-633249703f23","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":true,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"text-align:center;line-height:normal","Text":"ANNEX II","Underlined":false,"Uppercased":true},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-right:70.8pt;line-height:normal\"><\/p>","HasBorder":false,"ID":"842fc12e-7d3a-43a3-98ba-bc871a22108a","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-right:70.8pt;line-height:normal","Text":"","Underlined":false,"Uppercased":false},{"Bold":true,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\r 0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">A.      MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE\r SUBSTANCE(S) AND MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE<\/span><\/b><\/p>","HasBorder":false,"ID":"bf970ab7-3c0c-4009-be8f-897f5db02746","Indexed":true,"IsHeadingType":"L1","IsListItem":false,"IsPossibleHeading":true,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-top:0in;margin-right:70.8pt;margin-bottom:\r\n0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r\nnormal","Text":"A.      MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE\r SUBSTANCE(S) AND MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE","Underlined":false,"Uppercased":true},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><\/p>","HasBorder":false,"ID":"1b4f199b-8e2a-42e9-9326-9b551171b80e","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal","Text":"","Underlined":false,"Uppercased":false},{"Bold":true,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\r 0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">B.      CONDITIONS OR RESTRICTIONS REGARDING SUPPLY\r AND USE<\/span><\/b><\/p>","HasBorder":false,"ID":"ae333ff0-42c8-4311-b15e-42363b3b178d","Indexed":true,"IsHeadingType":"L1","IsListItem":false,"IsPossibleHeading":true,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-top:0in;margin-right:70.8pt;margin-bottom:\r\n0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r\nnormal","Text":"B.      CONDITIONS OR RESTRICTIONS REGARDING SUPPLY\r AND USE","Underlined":false,"Uppercased":true},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><\/p>","HasBorder":false,"ID":"8768afd6-5e4d-440e-85a5-68dd2410ccc3","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal","Text":"","Underlined":false,"Uppercased":false},{"Bold":true,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\r 0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">C.      OTHER CONDITIONS AND REQUIREMENTS OF THE\r MARKETING AUTHORISATION<\/span><\/b><\/p>","HasBorder":false,"ID":"da5478e1-b20f-45da-bfae-2a69f7577ead","Indexed":true,"IsHeadingType":"L1","IsListItem":false,"IsPossibleHeading":true,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-top:0in;margin-right:70.8pt;margin-bottom:\r\n0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r\nnormal","Text":"C.      OTHER CONDITIONS AND REQUIREMENTS OF THE\r MARKETING AUTHORISATION","Underlined":false,"Uppercased":true},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-right:77.9pt;line-height:normal\"><\/p>","HasBorder":false,"ID":"660830d5-3481-4555-a26c-8961aa81c914","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-right:77.9pt;line-height:normal","Text":"","Underlined":false,"Uppercased":false},{"Bold":true,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\r 0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">D.      <span style=\"text-transform:uppercase\">conditions\r or restrictions with regard to the safe and effective use of the medicinal\r PRODUCT<\/span><\/span><\/b><\/p>","HasBorder":false,"ID":"3e7a046d-087a-4716-b630-aba57db19cc7","Indexed":true,"IsHeadingType":"L1","IsListItem":false,"IsPossibleHeading":true,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-top:0in;margin-right:70.8pt;margin-bottom:\r\n0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r\nnormal","Text":"D.      conditions\r or restrictions with regard to the safe and effective use of the medicinal\r PRODUCT","Underlined":false,"Uppercased":true},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-right:70.8pt;line-height:normal\"><\/p>","HasBorder":false,"ID":"6210e13e-84af-41bd-9d00-d245ec30b438","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-right:70.8pt;line-height:normal","Text":"","Underlined":false,"Uppercased":false},{"Bold":true,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\r 0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">E.      SPECIFIC OBLIGATION TO COMPLETE\r POST-AUTHORISATION MEASURES FOR THE <\/span><\/b><b><span lang=\"EN-GB\">CONDITIONAL<\/span><span lang=\"EN-GB\"> MARKETING AUTHORISATION<\/span><\/b><\/p>","HasBorder":false,"ID":"f5a09e90-0e91-46de-8fe5-4aafc06539e7","Indexed":true,"IsHeadingType":"L1","IsListItem":false,"IsPossibleHeading":true,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-top:0in;margin-right:70.8pt;margin-bottom:\r\n0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r\nnormal","Text":"E.      SPECIFIC OBLIGATION TO COMPLETE\r POST-AUTHORISATION MEASURES FOR THE CONDITIONAL MARKETING AUTHORISATION","Underlined":false,"Uppercased":true},{"Bold":false,"Classes":"None","Element":"<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"\/> <\/span>","HasBorder":false,"ID":"46e5a1d1-e810-4074-938e-1851aaa00adb","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"font-size:11.0pt;font-family:\"Times New Roman\",serif","Text":" ","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"None","Element":"<br clear=\"all\" style=\"page-break-before:always\"\/>","HasBorder":false,"ID":"c3c7ce21-0f03-4f8a-bce9-7c00998926a6","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"46e5a1d1-e810-4074-938e-1851aaa00adb","Styles":"page-break-before:always","Text":"","Underlined":false,"Uppercased":false},{"Bold":true,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal\"><b><span lang=\"EN-GB\">A.      MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE\r SUBSTANCE(S) AND MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE<\/span><\/b><\/p>","HasBorder":false,"ID":"aca30bfc-bfd3-46a6-96ac-cf8c21830b16","Indexed":true,"IsHeadingType":"L1","IsListItem":false,"IsPossibleHeading":true,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal","Text":"A.      MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE\r SUBSTANCE(S) AND MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE","Underlined":false,"Uppercased":true},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-right:70.8pt;line-height:normal\"><\/p>","HasBorder":false,"ID":"6d109856-ade0-4633-9cd3-5e48c16fda00","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-right:70.8pt;line-height:normal","Text":"","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Name and address of the manufacturer(s) of the biological active\r substance(s)<\/span><\/u><\/p>","HasBorder":false,"ID":"6ffd3e14-d722-4e20-b122-28add17ea715","Indexed":false,"IsHeadingType":"L2","IsListItem":false,"IsPossibleHeading":true,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"line-height:normal;page-break-after:avoid","Text":"Name and address of the manufacturer(s) of the biological active\r substance(s)","Underlined":true,"Uppercased":false},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-right:70.8pt;line-height:normal;page-break-after:\r avoid\"><\/p>","HasBorder":false,"ID":"7f43d1d3-9bc5-4a8c-940c-27f6b94b3ee0","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-right:70.8pt;line-height:normal;page-break-after:\r\navoid","Text":"","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['Standard']","Element":"<p class=\"Standard\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis Pharma\r AG<\/span><\/p>","HasBorder":false,"ID":"4b6d20fe-5863-4505-b051-bafc723bb662","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"line-height:normal","Text":"Novartis Pharma\r AG","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['Standard']","Element":"<p class=\"Standard\" style=\"line-height:normal\"><span lang=\"DE-CH\">Lichtstrasse 35<\/span><\/p>","HasBorder":false,"ID":"370ada09-91d8-44c6-8fdd-7d31fe9232e7","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"line-height:normal","Text":"Lichtstrasse 35","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['Standard']","Element":"<p class=\"Standard\" style=\"line-height:normal\"><span lang=\"DE-CH\">4056 Basel<\/span><\/p>","HasBorder":false,"ID":"f4d96f8b-062e-45de-ade9-8204b077a3fd","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"line-height:normal","Text":"4056 Basel","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Switzerland<\/span><\/p>","HasBorder":false,"ID":"d97e4c04-c363-47d2-adb2-83a8a0d68963","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"line-height:normal","Text":"Switzerland","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","HasBorder":false,"ID":"9122a0f2-1243-413d-95e8-244d3dde678d","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"line-height:normal","Text":"","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Name and address of the manufacturer(s) responsible for batch\r release<\/span><\/u><\/p>","HasBorder":false,"ID":"0d9d09b4-2976-43b0-9d12-a8d06e1b17d2","Indexed":false,"IsHeadingType":"L2","IsListItem":false,"IsPossibleHeading":true,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"line-height:normal;page-break-after:avoid","Text":"Name and address of the manufacturer(s) responsible for batch\r release","Underlined":true,"Uppercased":false},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><\/p>","HasBorder":false,"ID":"f029c15b-a76e-4d4f-a20b-1c93d8ea63be","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"line-height:normal;page-break-after:avoid","Text":"","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['Standard']","Element":"<p class=\"Standard\" style=\"line-height:normal\">Novartis Pharma GmbH<\/p>","HasBorder":false,"ID":"e5275426-0c50-421c-a888-ff5de6f920f3","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"line-height:normal","Text":"Novartis Pharma GmbH","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['Standard']","Element":"<p class=\"Standard\" style=\"line-height:normal\">Roonstrasse 25<\/p>","HasBorder":false,"ID":"4a004d50-f899-4a9c-8952-416d390300fb","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"line-height:normal","Text":"Roonstrasse 25","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['Standard']","Element":"<p class=\"Standard\" style=\"line-height:normal\">90429 Nuremberg<\/p>","HasBorder":false,"ID":"10a595dc-fdd9-4e78-ba1b-b471d9ad7d40","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"line-height:normal","Text":"90429 Nuremberg","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"line-height:normal\">Germany<\/p>","HasBorder":false,"ID":"50e8875e-4d57-4a4f-9861-db43f80d3005","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"line-height:normal","Text":"Germany","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"> <\/p>","HasBorder":false,"ID":"54edb67d-6e31-41ab-b71a-11cec501ff87","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"line-height:normal","Text":" ","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"> <\/p>","HasBorder":false,"ID":"93c4b567-0d96-43e1-aad6-971f3cc0d2e6","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"line-height:normal","Text":" ","Underlined":false,"Uppercased":false},{"Bold":true,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;page-break-after:avoid\"><a name=\"OLE_LINK2\"><b><span lang=\"EN-GB\">B.<\/span><\/b><\/a><b><span lang=\"EN-GB\">      CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE<\/span><\/b><\/p>","HasBorder":false,"ID":"01bb9b60-0240-4204-9827-633663b0d458","Indexed":true,"IsHeadingType":"L1","IsListItem":false,"IsPossibleHeading":true,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal;page-break-after:avoid","Text":"B.      CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE","Underlined":false,"Uppercased":true},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><\/p>","HasBorder":false,"ID":"46304776-dda4-4c58-b211-b5e6a25b7917","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"line-height:normal;page-break-after:avoid","Text":"","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Medicinal\r product subject to restricted medical prescription (see Annex I: Summary of\r Product Characteristics, section 4.2).<\/span><\/p>","HasBorder":false,"ID":"354feddd-6c3e-4d54-a6a7-77b92f6fdbd3","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"line-height:normal","Text":"Medicinal\r product subject to restricted medical prescription (see Annex I: Summary of\r Product Characteristics, section 4.2).","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","HasBorder":false,"ID":"3666adec-74ac-4dba-abb7-8f93a46da350","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"line-height:normal","Text":"","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><\/p>","HasBorder":false,"ID":"e864852c-23e6-4de0-b7df-c2f4c1a2518b","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"line-height:normal","Text":"","Underlined":false,"Uppercased":false},{"Bold":true,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">C.      OTHER CONDITIONS AND\r REQUIREMENTS OF THE MARKETING AUTHORISATION<\/span><\/b><\/p>","HasBorder":false,"ID":"65a10f2a-d24a-4349-afa3-1bce67c9fa79","Indexed":true,"IsHeadingType":"L1","IsListItem":false,"IsPossibleHeading":true,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal;page-break-after:avoid","Text":"C.      OTHER CONDITIONS AND\r REQUIREMENTS OF THE MARKETING AUTHORISATION","Underlined":false,"Uppercased":true},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\r avoid\"><\/p>","HasBorder":false,"ID":"11f0070d-317f-41ea-9dab-09adb2c1836c","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-right:-.05pt;line-height:normal;page-break-after:\r\navoid","Text":"","Underlined":false,"Uppercased":false},{"Bold":true,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\r 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><b><span lang=\"EN-GB\">Periodic safety update reports (PSURs)<\/span><\/b><\/p>","HasBorder":false,"ID":"bf56e44e-209b-4c34-bd6d-7e0aa7efb7a4","Indexed":false,"IsHeadingType":"L2","IsListItem":true,"IsPossibleHeading":true,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-top:0in;margin-right:-.05pt;margin-bottom:\r\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r\nnormal;page-break-after:avoid","Text":"\u00b7Periodic safety update reports (PSURs)","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal;page-break-after:\r avoid\"><\/p>","HasBorder":false,"ID":"edb3838c-0576-4d8f-baa7-31203b129fcc","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-right:28.35pt;line-height:normal;page-break-after:\r\navoid","Text":"","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal\"><span lang=\"EN-GB\">The requirements for submission of PSURs for this medicinal product\r are set out in the list of Union reference dates (EURD list) <\/span><span lang=\"EN-GB\">provided for under Article 107c(7) of Directive 2001\/83<\/span><span lang=\"EN-GB\">\/EC<\/span><span lang=\"EN-GB\"> and <\/span><span lang=\"EN-GB\">any\r subsequent updates published on the European medicines web\u2011portal.<\/span><\/p>","HasBorder":false,"ID":"b9e41d91-eaae-4be0-bf45-2dade76190f9","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-right:28.35pt;line-height:normal","Text":"The requirements for submission of PSURs for this medicinal product\r are set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001\/83\/EC and any\r subsequent updates published on the European medicines web\u2011portal.","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal\"><\/p>","HasBorder":false,"ID":"fff60962-46d4-4f2f-bcf2-98448a9fa9cc","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-right:28.35pt;line-height:normal","Text":"","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The marketing\r authorisation holder (MAH) shall submit the first PSUR for this product within\r 6 months following authorisation.<\/span><\/p>","HasBorder":false,"ID":"e68cc5d4-2d52-4478-b422-ec1c03401107","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"line-height:normal","Text":"The marketing\r authorisation holder (MAH) shall submit the first PSUR for this product within\r 6 months following authorisation.","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><\/p>","HasBorder":false,"ID":"523bd917-15de-4b05-a8a3-94e7a4a20219","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-right:-.05pt;line-height:normal","Text":"","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><\/p>","HasBorder":false,"ID":"b3888cbc-1caf-4506-a626-06f37d2819a8","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-right:-.05pt;line-height:normal","Text":"","Underlined":false,"Uppercased":false},{"Bold":true,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">D.      CONDITIONS OR\r RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT<\/span><\/b><\/p>","HasBorder":false,"ID":"681d472b-fdf0-47a7-acf4-37cb132944d5","Indexed":true,"IsHeadingType":"L1","IsListItem":false,"IsPossibleHeading":true,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal;page-break-after:avoid","Text":"D.      CONDITIONS OR\r RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT","Underlined":false,"Uppercased":true},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\r avoid\"><\/p>","HasBorder":false,"ID":"0593194b-def9-491f-a47e-835c72ee2a8b","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-right:-.05pt;line-height:normal;page-break-after:\r\navoid","Text":"","Underlined":false,"Uppercased":false},{"Bold":true,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\r 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><b><span lang=\"EN-GB\">Risk management plan (RMP)<\/span><\/b><\/p>","HasBorder":false,"ID":"0d01587a-3558-41e5-955e-349bef4f5eae","Indexed":false,"IsHeadingType":"L2","IsListItem":true,"IsPossibleHeading":true,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-top:0in;margin-right:-.05pt;margin-bottom:\r\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r\nnormal;page-break-after:avoid","Text":"\u00b7Risk management plan (RMP)","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\r avoid\"><\/p>","HasBorder":false,"ID":"c6d600b4-338a-437c-8cbf-2842c926f4b8","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-right:-.05pt;line-height:normal;page-break-after:\r\navoid","Text":"","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal\"><span lang=\"EN-GB\">The <\/span><span lang=\"EN-GB\">marketing<\/span><span lang=\"EN-GB\">\r authorisation holder (<\/span><span lang=\"EN-GB\">MAH) shall perform the required\r pharmacovigilance activities and interventions detailed in the agreed RMP\r presented in Module 1.8.2 of the marketing authorisation and any agreed\r subsequent updates of the RMP.<\/span><\/p>","HasBorder":false,"ID":"bfbbefd8-9f9a-415b-b593-93b1e8325cf3","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-right:28.35pt;line-height:normal","Text":"The marketing\r authorisation holder (MAH) shall perform the required\r pharmacovigilance activities and interventions detailed in the agreed RMP\r presented in Module 1.8.2 of the marketing authorisation and any agreed\r subsequent updates of the RMP.","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><\/p>","HasBorder":false,"ID":"1708f936-b08e-46fb-ac73-26a83ca05e5d","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-right:-.05pt;line-height:normal","Text":"","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">An updated RMP should be submitted:<\/span><\/p>","HasBorder":false,"ID":"d4ef9923-daeb-4dd4-b4d6-0d0057cfa59d","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"line-height:normal;page-break-after:avoid","Text":"An updated RMP should be submitted:","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\r 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">At the request of the European Medicines Agency;<\/span><\/p>","HasBorder":false,"ID":"3a724f2c-db34-4729-b7b0-9bfce73b35c2","Indexed":false,"IsHeadingType":null,"IsListItem":true,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-top:0in;margin-right:-.05pt;margin-bottom:\r\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r\nnormal","Text":"\u00b7At the request of the European Medicines Agency;","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\r 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<\/span><span lang=\"EN-GB\">Whenever the risk management system is modified,\r especially as the result of new information being received that may lead to a\r significant change to the benefit\/risk profile or as the result of an important\r (pharmacovigilance or risk minimisation) milestone being reached.<\/span><\/p>","HasBorder":false,"ID":"4780f7e4-93c0-464d-8ba7-da3dd7d90b7d","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-top:0in;margin-right:-.05pt;margin-bottom:\r\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\r\nnormal","Text":"\u00b7Whenever the risk management system is modified,\r especially as the result of new information being received that may lead to a\r significant change to the benefit\/risk profile or as the result of an important\r (pharmacovigilance or risk minimisation) milestone being reached.","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['MsoNormal']","Element":"<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><\/p>","HasBorder":false,"ID":"aa5ab73f-29e9-4f53-8992-91e71464c96b","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-right:-.05pt;line-height:normal","Text":"","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['Standard']","Element":"<p class=\"Standard\" style=\"margin-right:-.05pt;line-height:normal\"><\/p>","HasBorder":false,"ID":"f11902a6-c4ce-4d07-bfec-dd331f546070","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-right:-.05pt;line-height:normal","Text":"","Underlined":false,"Uppercased":false},{"Bold":true,"Classes":"['Standard']","Element":"<p class=\"Standard\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">E.      SPECIFIC OBLIGATION\r TO COMPLETE POST-AUTHORISATION MEASURES FOR THE CONDITIONAL MARKETING\r AUTHORISATION<\/span><\/b><\/p>","HasBorder":false,"ID":"6b9c02e4-a6d6-456d-a50b-be08141ad3fd","Indexed":true,"IsHeadingType":"L1","IsListItem":false,"IsPossibleHeading":true,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-left:28.35pt;text-indent:-28.35pt;line-height:\r\nnormal;page-break-after:avoid","Text":"E.      SPECIFIC OBLIGATION\r TO COMPLETE POST-AUTHORISATION MEASURES FOR THE CONDITIONAL MARKETING\r AUTHORISATION","Underlined":false,"Uppercased":true},{"Bold":false,"Classes":"['Standard']","Element":"<p class=\"Standard\" style=\"line-height:normal;page-break-after:avoid\"><\/p>","HasBorder":false,"ID":"82f3b029-1424-433a-8f81-65751811b8aa","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"line-height:normal;page-break-after:avoid","Text":"","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['Standard']","Element":"<p class=\"Standard\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\r avoid\"><span lang=\"EN-GB\">This being a conditional marketing authorisation and\r pursuant to Article 14a(4) of Regulation (EC) No 726\/2004, the MAH shall\r complete, within the stated timeframe, the following measures:<\/span><\/p>","HasBorder":false,"ID":"62687de8-07cd-43ac-9485-b2ef72c90ad2","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-right:-.05pt;line-height:normal;page-break-after:\r\navoid","Text":"This being a conditional marketing authorisation and\r pursuant to Article 14a(4) of Regulation (EC) No 726\/2004, the MAH shall\r complete, within the stated timeframe, the following measures:","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['Standard']","Element":"<p class=\"Standard\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\r avoid\"><\/p>","HasBorder":false,"ID":"6ff9b4bd-82e2-47e0-8aed-bde83c90b84d","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"margin-right:-.05pt;line-height:normal;page-break-after:\r\navoid","Text":"","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"['NormaleTabelle']","Element":"<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"NormaleTabelle\" style=\"border-collapse:collapse;border:none\" width=\"100%\"> <tr style=\"page-break-inside:avoid\"> <td style=\"width:82.18%;border:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"82%\"> <p class=\"Standard\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\r   avoid\"><b><span lang=\"EN-GB\">Description<\/span><\/b><\/p> <\/td> <td style=\"width:17.82%;border:solid windowtext 1.0pt;\r   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\"> <p class=\"Standard\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\r   avoid\"><b><span lang=\"EN-GB\">Due date<\/span><\/b><\/p> <\/td> <\/tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:82.18%;border:solid windowtext 1.0pt;\r   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"82%\"> <p class=\"TabletextrowsAgency\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>In\r   order to confirm the efficacy and safety of crizanlizumab, the MAH should\r   submit the results of the primary analysis of a phase III CSEG101A2301 study\r   of crizanlizumab with or without hydroxyurea\/hydroxycarbamide in adolescent\r   and adult sickle cell disease patients with vaso-occlusive crises<\/span><\/p> <\/td> <td style=\"width:17.82%;border-top:none;border-left:\r   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\"> <p class=\"TabletextrowsAgency\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Clinical\r   study report primary analysis:<\/span><\/p> <p class=\"TabletextrowsAgency\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>December\r   2025<\/span><\/p> <\/td> <\/tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:82.18%;border:solid windowtext 1.0pt;\r   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"82%\"> <p class=\"TabletextrowsAgency\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>In\r   order to confirm the efficacy and safety of crizanlizumab, the MAH should\r   submit the final results of the phase II CSEG101A2202 study of\r   crizanlizumab with or without hydroxyurea\/hydroxycarbamide in sickle cell\r   disease patients with vaso\u2011occlusive crisis.<\/span><\/p> <\/td> <td style=\"width:17.82%;border-top:none;border-left:\r   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\r   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\"> <p class=\"TabletextrowsAgency\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Clinical\r   study report:<\/span><\/p> <p class=\"TabletextrowsAgency\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>December\r   2025<\/span><\/p> <\/td> <\/tr> <\/table>","HasBorder":false,"ID":"6d6c3bde-013a-4db7-8d21-07dedc5c87a3","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"border-collapse:collapse;border:none","Text":"   Description   Due date     In\r   order to confirm the efficacy and safety of crizanlizumab, the MAH should\r   submit the results of the primary analysis of a phase III CSEG101A2301 study\r   of crizanlizumab with or without hydroxyurea\/hydroxycarbamide in adolescent\r   and adult sickle cell disease patients with vaso-occlusive crises   Clinical\r   study report primary analysis: December\r   2025     In\r   order to confirm the efficacy and safety of crizanlizumab, the MAH should\r   submit the final results of the phase II CSEG101A2202 study of\r   crizanlizumab with or without hydroxyurea\/hydroxycarbamide in sickle cell\r   disease patients with vaso\u2011occlusive crisis.   Clinical\r   study report: December\r   2025   ","Underlined":false,"Uppercased":false},{"Bold":false,"Classes":"None","Element":"<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"\/> <\/span>","HasBorder":false,"ID":"c36bf53f-f82a-4148-aded-be1b26bfd835","Indexed":false,"IsHeadingType":null,"IsListItem":false,"IsPossibleHeading":false,"Italics":false,"ParentId":"155d0d9d-951c-4476-be73-69a4707fa784","Styles":"font-size:11.0pt;font-family:\"Times New Roman\",serif","Text":" ","Underlined":false,"Uppercased":false}]